Ophthalmic Agent's Flashcards
(70 cards)
Prostaglandin analogue example
Latanoprost
Beta blocker example
Timolol
Alpha 2 adrenomimetics example
Brimonidine
Carbonic anhydrase inhibitor
Dorzolamide, Acetazolamide
Osmotic diuretic
Mannitol
M- cholinomimetics
Pilocarpine
Steroidal and non steroidal anti inflammatory drugs
Dexamethasone and diclofenac
Angiogenesis inhibitors
Bevacizumab
Mydriatic and cycloplegic agents
Atropine
Glaucoma caused by
Dysbalance between intraocular fluid production and outflow - elevated intraocular pressure,progress slowly
Intraocular pressure can be elevated by drugs with
Anticholinergic effect
Consequence of untreated glaucoma
Total optic nerve atrophy
Types of glaucoma
Open angle glaucoma and closed angle glaucoma ( acute state)
If IOP doesn’t reach target with maximal triple therapy and optic nerve damage progresses next option is
Surgical treatment or laser therapy
Cataract
Clouding of natural lens of eye, usually associated with aging, circulatory and hormonal changes,long term use of drugs like corticosteroids.Mostbeffective treatment method is surgery
Intra ocular pressure reduction mechanisms
IOF production reduction,IOF uveoscleral outflow stimulation, Stimulation of IOF trabecular outflow,IOF osmotic outflow stimulation
IOF production reduction can be done using
Beta blockers, Alpha 2 adrenomimetics, carbonic anhydrase inhibitor
IOF uveoscleral outflow stimulation can be done using
Prostaglandin analogue and alpha 2 adrenomimetics
Stimulation of IOF trabecular outflow can be done by using
M cholinoreceptor agonist
IOF osmotic outflow stimulation can be done bynusing
Osmotic diuretics
Alpha 2 adrenomimetics helps to
Reduce IOf production and and increase IOF uveoscleral outflow
Beta blockers in glaucoma helps to
Reduce IOF production
Latanoprost ( prostaglandin analogue) action
PGF2 alpha receptor agonist,it stimulate intraocular fluid uveoscleral outflow and decrease IOP
Anti glaucoma effect
Clinical use of latanoprost (prostaglandin analogue)
For the reduction of elevated IOP in patients with open angle glaucoma and ocular hypertension